On Tuesday, the US Department of Health and Human Services disclosed the end of funding for 22 mRNA vaccine projects — a decision affecting nearly $500 million in federal investments. The announcement ...

In Danes over age 65, the vaccine effectiveness of the JN.1-based mRNA boosters reached 70-85% against COVID-related hospitalization and 76-96% against COVID-associated death. Effectiveness didn't ...

RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA ...

Simultaneous administration of a COVID-19 mRNA booster shot and the seasonal influenza vaccine slightly increased the risk of systemic reactions during the following week compared with a booster shot ...

Adults in England aged 50 years or older who received the bivalent BA.1 mRNA booster vaccine during the 2022 autumn campaign had substantially lower risks for COVID-related hospitalisation and death ...

Add Yahoo as a preferred source to see more of our stories on Google. Health and Human Services Secretary Robert F. Kennedy Jr. canceled $500 million of funding for research on mRNA vaccine technology ...

Add Yahoo as a preferred source to see more of our stories on Google. RFK Jr. canceled $500 million of funding for research on mRNA vaccine technology. Anadolu/Getty Images At a Sept. 4, 2025, hearing ...

A new Centers for Disease Control and Prevention study says booster shots of Pfizer's and Moderna's COVID-19 vaccines proved vital in keeping additional Americans out of the hospital as the omicron ...

Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Monash University in Australia have demonstrated that an intranasal vaccine booster may confer ...